Cerebral pachyleptomeningitis associated with MPO-ANCA induced by PTU therapy

Takato Abe, Shigeru Nogawa, Norio Tanahashi, Junichi Shiraishi, Eiji Ikeda, Norihiro Suzuki

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A 34-year-old woman with hyperthyroidism, who had been previously treated with propylthiouracil (PTU) is reported. She was admitted because of clumsiness in her left hand and abnormal behavior. A neurological examination demonstrated impairment of higher cortical function, and weakness and hyperreflexia of the left leg. An MRI scan with gadolinium enhancement showed pachyleptomeningeal thickening in the right fronto-parietal lobe. Blood tests revealed a high MPO-ANCA titer of 122 EU (normal:<10 EU). After steroid administration, the neurological symptoms and the MRI findings improved markedly. This is the first report of PTU-induced cerebral pachyleptomeningitis associated with a high serum MPO-ANCA titer.

Original languageEnglish
Pages (from-to)247-250
Number of pages4
JournalInternal Medicine
Volume46
Issue number5
DOIs
Publication statusPublished - 2007 Mar 1

    Fingerprint

Keywords

  • MPO-ANCA
  • PTU
  • Pachyleptomeningitis

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Abe, T., Nogawa, S., Tanahashi, N., Shiraishi, J., Ikeda, E., & Suzuki, N. (2007). Cerebral pachyleptomeningitis associated with MPO-ANCA induced by PTU therapy. Internal Medicine, 46(5), 247-250. https://doi.org/10.2169/internalmedicine.46.1859